S Richards

5.9k total citations · 1 hit paper
40 papers, 3.5k citations indexed

About

S Richards is a scholar working on Public Health, Environmental and Occupational Health, Hematology and Genetics. According to data from OpenAlex, S Richards has authored 40 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Public Health, Environmental and Occupational Health, 13 papers in Hematology and 7 papers in Genetics. Recurrent topics in S Richards's work include Acute Lymphoblastic Leukemia research (23 papers), Childhood Cancer Survivors' Quality of Life (7 papers) and Acute Myeloid Leukemia Research (6 papers). S Richards is often cited by papers focused on Acute Lymphoblastic Leukemia research (23 papers), Childhood Cancer Survivors' Quality of Life (7 papers) and Acute Myeloid Leukemia Research (6 papers). S Richards collaborates with scholars based in United Kingdom, United States and Canada. S Richards's co-authors include Barbara Farrell, C Warlow, Jon Godwin, C. C. Bailey, N. C. Allan, J M Chessells, J S Lilleyman, Judith M. Chessells, Ajay Vora and Christopher Mitchell and has published in prestigious journals such as The Lancet, Journal of Clinical Investigation and Blood.

In The Last Decade

S Richards

39 papers receiving 3.3k citations

Hit Papers

The United Kingdom transi... 1991 2026 2002 2014 1991 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. The United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: final results.
    1991 862 citations S Richards et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
S Richards 1.2k 1.0k 752 546 456 40 3.5k
Denis R. Miller 720 0.6× 985 0.9× 654 0.9× 184 0.3× 280 0.6× 98 2.7k
Attilio Rovelli 581 0.5× 1.3k 1.3× 588 0.8× 488 0.9× 224 0.5× 118 3.0k
David Taube 447 0.4× 608 0.6× 254 0.3× 494 0.9× 876 1.9× 151 4.5k
Liton Francisco 1.2k 1.0× 1.7k 1.7× 1.5k 2.0× 146 0.3× 312 0.7× 109 3.9k
Pedro A. de Alarcón 355 0.3× 429 0.4× 357 0.5× 169 0.3× 378 0.8× 91 2.6k
Dieter Körholz 636 0.5× 415 0.4× 402 0.5× 258 0.5× 841 1.8× 138 3.1k
Tobias Wirenfeldt Klausen 541 0.5× 1.1k 1.0× 392 0.5× 227 0.4× 278 0.6× 143 3.3k
Thomas Wiebe 474 0.4× 308 0.3× 602 0.8× 233 0.4× 1.0k 2.2× 115 2.9k
Markus Metzler 570 0.5× 787 0.8× 246 0.3× 167 0.3× 543 1.2× 130 2.8k
I. Quéré 183 0.2× 1.4k 1.4× 425 0.6× 200 0.4× 791 1.7× 233 5.4k

Countries citing papers authored by S Richards

Since Specialization
Citations

This map shows the geographic impact of S Richards's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S Richards with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S Richards more than expected).

Fields of papers citing papers by S Richards

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S Richards. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S Richards. The network helps show where S Richards may publish in the future.

Co-authorship network of co-authors of S Richards

This figure shows the co-authorship network connecting the top 25 collaborators of S Richards. A scholar is included among the top collaborators of S Richards based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S Richards. S Richards is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shankar, Ganesh M., Steven Arkin, Viswanath Devanarayan, et al.. (2014). Assessment and Reporting of the Clinical Immunogenicity of Therapeutic Proteins and Peptides—Harmonized Terminology and Tactical Recommendations. The AAPS Journal. 16(4). 658–673. 236 indexed citations
2.
Buitenkamp, Trudy, Rob Pieters, Arian van der Veer, et al.. (2012). Outcome in children with Down's syndrome and acute lymphoblastic leukemia: role of IKZF1 deletions and CRLF2 aberrations. Leukemia. 26(10). 2204–2211. 74 indexed citations
3.
Wade, Rachel, Maria Chiara Di Bernardo, S Richards, et al.. (2011). Association between single nucleotide polymorphism-genotype and outcome of patients with chronic lymphocytic leukemia in a randomized chemotherapy trial. Haematologica. 96(10). 1496–1503. 14 indexed citations
4.
Patel, Bijendra, S Richards, Jacob M. Rowe, A. H. Goldstone, & Adele K. Fielding. (2007). High incidence of avascular necrosis in adolescents with acute lymphoblastic leukaemia: a UKALL XII analysis. Leukemia. 22(2). 308–312. 66 indexed citations
5.
Lennard, Lynne, Ajay Vora, Sally E. Kinsey, et al.. (2003). Thioguanine-related veno-occlusive disease of the liver in children with acute lymphoblastic leukaemia. British Journal of Clinical Pharmacology. 55(4). 437.
6.
Harewood, Louise, Hazel M. Robinson, Rachel L. Harris, et al.. (2003). Amplification of AML1 on a duplicated chromosome 21 in acute lymphoblastic leukemia: a study of 20 cases. Leukemia. 17(3). 547–553. 100 indexed citations
7.
Chessells, Judith M., et al.. (2002). Treatment of infants with lymphoblastic leukaemia: results of the UK Infant Protocols 1987–1999. British Journal of Haematology. 117(2). 306–314. 48 indexed citations
8.
Hargrave, Darren, Ian Hann, S Richards, et al.. (2001). Progressive reduction in treatment‐related deaths in Medical Research Council childhood lymphoblastic leukaemia trials from 1980 to 1997 (UKALL VIII, X and XI). British Journal of Haematology. 112(2). 293–299. 58 indexed citations
9.
Harrison, G, S Richards, Sarah Lawson, et al.. (2000). Comparison of allogeneic transplant versus chemotherapy for relapsed childhood acute lymphoblastic leukaemia in the MRC UKALL R1 trial. Annals of Oncology. 11(8). 999–1006. 28 indexed citations
10.
Chessells, Judith M., G. John Swansbury, B.R. Reeves, C. C. Bailey, & S Richards. (1997). Cytogenetics and prognosis in childhood lymphoblastic leukaemia: results of MRC UKALL X. British Journal of Haematology. 99(1). 93–100. 112 indexed citations
11.
Richards, S. (1997). 8 Interferon-α: results from randomized trials. Baillière s Clinical Haematology. 10(2). 307–318. 11 indexed citations
12.
13.
14.
Chessells, J M, C. C. Bailey, & S Richards. (1995). Intensification of treatment and survival in all children with lymphoblastic leukaemia: results of UK Medical Research Council trial UKALL X. The Lancet. 345(8943). 143–148. 222 indexed citations
15.
16.
Eden, O. B., J S Lilleyman, & S Richards. (1990). Testicular irradiation in childhood lymphoblastic leukaemia. British Journal of Haematology. 75(4). 496–498. 24 indexed citations
17.
Eden, O B, M. P. Shaw, J S Lilleyman, & S Richards. (1990). Non‐randomised study comparing toxicity of escherichia coli and erwinia asparaginase in children with leukaemia. Medical and Pediatric Oncology. 18(6). 497–502. 65 indexed citations
18.
Catovsky, Daniel, J. Fooks, & S Richards. (1988). The UK Medical Research Council CLL trials 1 and 2.. PubMed. 30(5-6). 423–7. 22 indexed citations
19.
Chessells, Judith M., et al.. (1987). Oral methotrexate is as effective as intramuscular in maintenance therapy of acute lymphoblastic leukaemia.. Archives of Disease in Childhood. 62(2). 172–176. 24 indexed citations
20.
Blamey, R.W., J. D. Briggs, J E Castro, et al.. (1983). MEDICAL RESEARCH COUNCIL TRIAL OF ANTILYMPHOCYTE GLOBULIN IN RENAL TRANSPLANTATION. Transplantation. 35(6). 539–545. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Denis R. Miller Breakdown of academic impact, for papers by Attilio Rovelli Breakdown of academic impact, for papers by David Taube Breakdown of academic impact, for papers by Liton Francisco Breakdown of academic impact, for papers by Pedro A. de Alarcón Breakdown of academic impact, for papers by Dieter Körholz Breakdown of academic impact, for papers by Tobias Wirenfeldt Klausen Breakdown of academic impact, for papers by Thomas Wiebe Breakdown of academic impact, for papers by Markus Metzler Breakdown of academic impact, for papers by I. Quéré
Rankless by CCL
2026